References
- Abo-Haded, H.M., et al., 2017. Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity. PLOS one, 12(3), e0174295.
- Arici, O.F. and Çetin, N., 2011. Protective role of ghrelin against carbon tetrachloride (CCl4)-induced coagulation disturbances in rats. Regulatory peptides, 166(1–3), 139–142.
- Byass, P., 2014. The global burden of liver disease: a challenge for methods and for public health. BMC medicine, 12(1), 159.
- Chamulitrat, W., Jordan, S.J., and Mason, R.P., 1994. Nitric oxide production during endotoxic shock in carbon tetrachloride-treated rats. Molecular pharmacology, 46(2), 391–397.
- Cheng, B.-Q., et al., 2007. Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. Pancreas, 35(3), 256–261.
- Clawson, G.A., 1989. Mechanisms of carbon tetrachloride hepatotoxicity. Pathology and immunopathology research, 8(2), 104–112.
- Das, U.N., 2006. Is pyruvate an endogenous anti-inflammatory molecule? Nutrition, 22(9), 965–972.
- Dong, W., et al., 1998. Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms. Toxicology and applied pharmacology, 151(2), 359–366.
- Drabkin, D.L., 1946. Spectrophotometric studies: the crystallographic and optical properties of the hemoglobin of man in comparison with those of other species. The journal of biological chemistry, 164(2), 703–723.
- Fink, M.P., 2008. Ethyl pyruvate. Current opinion in anaesthesiology, 21(2), 160–167.
- Grant, D.M., 1991. Detoxification pathways in the liver. Journal of inherited metabolic disease, 14, 421–430.
- Green, L.C., et al., 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Analytical biochemistry, 126(1), 131–138.
- Gu, X. and Manautou, J.E., 2012. Molecular mechanisms underlying chemical liver injury. Expert reviews in molecular medicine, 14, e4.
- Hamadi, N., et al., 2012. Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats. Journal of biochemical and molecular toxicology, 26(10), 384–392.
- Hauser, B., et al., 2005. Ethyl pyruvate improves systemic and hepatosplanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia. Critical care medicine, 33(9), 2034–2042.
- Jiang, L., et al., 2012. Metabonomic analysis reveals the CCl4-induced systems alterations for multiple rat organs. Journal of proteome research, 11(7), 3848–3859.
- Kannan, K. and Jain, S.K., 2000. Oxidative stress and apoptosis. Pathophysiology: the official journal of the international society for pathophysiology, 7(3), 153–163.
- Kao, K.K. and Fink, M.P., 2010. The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochemical pharmacology, 80(2), 151–159.
- Lee, J., et al., 2008. Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats. Human and experimental toxicology, 27(1), 49–54.
- Lowry, O.H., et al., 1951. Protein measurement with the Folin phenol reagent. The journal of biological chemistry, 193(1), 265–275.
- Lu, Y., et al., 2016. Protective effect of wedelolactone against CCl4-induced acute liver injury in mice. International immunopharmacology, 34, 44–52.
- Luck, H., 1965. Catalase. In: H. Bergmeyer, ed. Methods of enzymatic analysis. New York, NY: Academic Press, 885–884.
- Malaguarnera, G., et al., 2012. Toxic hepatitis in occupational exposure to solvents. World journal of gastroenterology, 18(22), 2756–2766.
- Manıbusan, M.K., Odın, M., and Eastmond, D.A., 2007. Postulated carbon tetrachloride mode of action: a review. Journal of environmental science and health, part C, 25(3), 185–209.
- Matsuda, K., 1994. ACAT inhibitors as antiatherosclerotic agents: compounds and mechanisms. Medicinal research reviews, 14(3), 271–305.
- Ohkawa, H., Ohishi, N., and Yagi, K., 1978. Reaction of linoleic acid hydroperoxide with thiobarbituric acid. Journal of lipid research, 19(8), 1053–1057.
- Ohta, Y., et al., 2000. Therapeutic effect of melatonin on carbon tetrachloride-induced acute liver injury in rats. Journal of pineal research, 28(2), 119–126.
- Paglia, D.E. and Valentine, W.N., 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. The journal of laboratory and clinical medicine, 70(1), 158–169.
- Payabvash, S., et al., 2008. Ethyl pyruvate reduces germ cell-specific apoptosis and oxidative stress in rat model of testicular torsion/detorsion. Journal of pediatric surgery, 43(4), 705–712.
- Reade, M.C. and Fink, M.P., 2005. Bench-to-bedside review: amelioration of acute renal impairment using ethyl pyruvate. Critical care, 9(6), 556–560.
- Reyes-Gordillo, K., et al., 2012. Protective effects of thymosin β4 on carbon tetrachloride-induced acute hepatotoxicity in rats. Annals of the New York academy of sciences, 1269(1), 61–68.
- Rosales-Corral, S., et al., 2010. Functional aspects of redox control during neuroinflammation. Antioxidants and redox signaling, 13(2), 193–247.
- Schultz, D.R. and Harrington, W.J., 2003. Apoptosis: programmed cell death at a molecular level. Seminars in arthritis and rheumatism, 32(6), 345–369.
- Sharma, A.B., et al., 2008. Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation. Resuscitation, 76(1), 108–119.
- Shen, F., et al., 2018. Ethyl pyruvate can alleviate alcoholic liver disease through inhibiting Nrf2 signaling pathway. Experimental and therapeutic medicine, 15(5), 4223–4228.
- Shi, J., et al., 1998. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. The American journal of pathology, 153(2), 515–525.
- Sileri, P., et al., 2001. Pyruvate inhibits hepatic ischemia-reperfusion injury in rats. Transplantation, 72(1), 27–30.
- Sun, Y., Oberley, L.W., and Li, Y., 1988. A simple method for clinical assay of superoxide dismutase. Clinical chemistry, 34(3), 497–500.
- Taniguchi, M., et al., 2004. Molecular process in acute liver injury and regeneration induced by carbon tetrachloride. Life sciences, 75(13), 1539–1549.
- Tawadrous, Z.S., Delude, R.L., and Fink, M.P., 2002. Resuscitation from hemorrhagic shock with Ringer’s ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock, 17(6), 473–477.
- Tipoe, G.L., et al., 2006. Inhibitors of inducible nitric oxide (NO) synthase are more effective than an NO donor in reducing carbon-tetrachloride induced acute liver injury. Histology and histopathology, 21(11), 1157–1165.
- Tsung, A., et al., 2005. Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation, 79(2), 196–204.
- Venkataraman, R., et al., 2002. Resuscitation with Ringer’s ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock, 18(6), 507–512.
- Wang, L.W., 2012. Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats. World journal of gastroenterology, 18(40), 5709.
- Weber, L.W.D., Boll, M., and Stampfl, A., 2003. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Critical reviews in toxicology, 33(2), 105–136.
- Winterbourn, C.C., et al., 1975. The estimation of red cell superoxide dismutase activity. The journal of laboratory and clinical medicine, 85(2), 337–341.
- Yoshioka, T., et al., 1979. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. American journal of obstetrics and gynecology, 135(3), 372–376.
- Zhang, Y., et al., 2009. Effect of ethyl pyruvate on physical and immunological barriers of the small intestine in a rat model of sepsis. The journal of trauma: injury, infection, and critical care, 66(5), 1355–1364.